The present invention relates to tricyclic 2-pyridone compounds of formula (I):
##STR1##
or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable
salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase,
and to pharmaceutical compositions and diagnostic kits comprising the same, and
methods of using the same for treating viral infection or as an assay standard
or reagent.